Financial reports
10-K
2023 FY
Annual report
21 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
10 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
10-K
2022 FY
Annual report
16 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
17 Mar 22
10-Q
2021 Q3
Quarterly report
12 Nov 21
Current reports
8-K
Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
21 Mar 24
8-K
Other Events
21 Feb 24
8-K
Apyx Medical Corporation Announces Peer-Reviewed Clinical Publication
22 Jan 24
8-K
Apyx Medical Corporation Reports Preliminary Fourth Quarter and Full Year 2023 Revenue Results
8 Jan 24
8-K
Apyx Medical Corporation Appoints Matthew Hill as Chief Financial Officer
28 Nov 23
8-K
Departure of Directors or Certain Officers
16 Nov 23
8-K
Apyx Medical Corporation Announces New Debt Facility with Perceptive Advisors
9 Nov 23
8-K
Apyx Medical Corporation Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Outlook
9 Nov 23
8-K
Submission of Matters to a Vote of Security Holders
16 Aug 23
8-K
Apyx Medical Corporation Reports Second Quarter 2023 Financial Results and Reaffirms Full Year 2023 Financial Outlook
10 Aug 23
Registration and prospectus
S-8
Registration of securities for employees
16 Nov 23
S-8
Registration of securities for employees
16 Nov 23
S-3/A
Shelf registration (amended)
2 Dec 22
S-3
Shelf registration
22 Nov 22
S-8
Registration of securities for employees
18 Aug 21
S-8
Registration of securities for employees
28 Sep 19
8-A12B/A
Registration of securities on exchange (amended)
31 Dec 18
25
Voluntary exchange delisting
31 Dec 18
S-3/A
Shelf registration (amended)
16 May 18
S-3
Shelf registration
4 May 18
Proxies
DEF 14A
Definitive proxy
23 Jun 23
DEF 14A
Definitive proxy
24 Jun 22
DEFA14A
Additional proxy soliciting materials
6 Jul 21
DEF 14A
Definitive proxy
25 Jun 21
DEFA14A
Additional proxy soliciting materials
30 Jun 20
DEF 14A
Definitive proxy
26 Jun 20
DEF 14A
Definitive proxy
21 Jun 19
DEF 14A
Definitive proxy
27 Jul 18
PRE 14A
Preliminary proxy
17 Jul 18
DEFA14A
Additional proxy soliciting materials
28 Aug 17
Other
SD
Conflict minerals disclosure
31 May 23
EFFECT
Notice of effectiveness
5 Dec 22
CORRESP
Correspondence with SEC
30 Nov 22
UPLOAD
Letter from SEC
30 Nov 22
SD
Conflict minerals disclosure
27 May 22
SD
Conflict minerals disclosure
26 May 21
SD
Conflict minerals disclosure
1 Jun 20
SD
Conflict minerals disclosure
31 May 19
CERT
Certification of approval for exchange listing
2 Jan 19
SD
Conflict minerals disclosure
24 May 18
Ownership
SC 13D
Archon Capital Management LLC
5 Apr 24
SC 13D
Vizirgianakis Stavros G.
1 Apr 24
SC 13G/A
HIRSCHMAN ORIN
25 Mar 24
SC 13G/A
PURA VIDA INVESTMENTS, LLC
14 Feb 24
SC 13G/A
Divisadero Street Capital Management, LP
14 Feb 24
SC 13G/A
RTW INVESTMENTS, LP
14 Feb 24
SC 13G/A
Archon Capital Management LLC
13 Feb 24
SC 13G/A
HIRSCHMAN ORIN
7 Feb 24
SC 13G/A
Cowen Financial Products LLC
2 Feb 24
SC 13G
ROYCE & ASSOCIATES LP
23 Jan 24